Topics

AUM Biosciences looks to advance anti-cancer molecule to Phase 2 later this year

04:47 EST 20 Feb 2019 | Proactive Investors

AUM Biosciences CEO Vishal Doshi sat down with Proactive Investors at the BIO CEO and Investor Conference in New York.

AUM Biosciences is a Singapore-based oncology-focused biotech company.

Original Article: AUM Biosciences looks to advance anti-cancer molecule to Phase 2 later this year

NEXT ARTICLE

More From BioPortfolio on "AUM Biosciences looks to advance anti-cancer molecule to Phase 2 later this year"

Quick Search

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...